InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Reports Financials, Advances NV-387 Antiviral Trials
NanoViricides, Inc. (NYSE American: NNVC) has filed its quarterly report for the period ending Dec. 31, 2024, with the SEC, reporting cash and cash equivalents of $3.96 million and net property and equipment assets of $7.17 million. The company raised $4 million through an At-the-Market offering but indicated it lacks sufficient funding to sustain operations through February 2026 without additional financing. NanoViricides is advancing its…